Trials / Withdrawn
WithdrawnNCT01952925
Combined Afib Ablation and RA Denervation for the Maintenance of Sinus Rhythm and Management of Resistant Hypertension
Combined Atrial Fibrillation Ablation and Renal Artery Denervation for the Maintenance of Sinus Rhythm and Management of Resistant Hypertension
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Oregon Health and Science University · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to perform renal artery denervation at the same time as atrial fibrillation ablation. RA denervation may reduce blood pressure, increase the chances of a successful atrial fibrillation ablation, and decrease the number of medications required to control blood pressure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Renal Artery denervation | RA denervation performed as part of afib ablation procedure |
Timeline
- Start date
- 2019-03-01
- Primary completion
- 2019-03-01
- Completion
- 2019-03-01
- First posted
- 2013-09-30
- Last updated
- 2019-02-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01952925. Inclusion in this directory is not an endorsement.